CVS Health Chair David Dorman and Director Tony White to retire; Roger Farah named next Chair

CVS HEALTH Corp

David W. Dorman will retire as Independent Chair effective May 11, 2022, and will not stand for re-election.
Tony L. White will also retire from the Board at the May 11 annual meeting due to mandatory retirement age.
Roger N. Farah, independent director since 2018, unanimously selected as new Independent Chair, effective May 11, 2022.
Board size will be reduced to 11 directors following the retirements.
Dorman's retirement is not due to any disagreement with CVS Health.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David W. Dorman

Chair of the Board

CVS · CVS HEALTH Corp

Effective: 2022-05-11
Successor: Roger N. Farah
Filed: March 10, 2022, 6:59 PM ET

David W. Dorman, the current Chair of the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health”), informed the Board that he intends to retire at the end of his current term and will not stand for re-election at the Annual Meeting of Stockholders on May 11, 2022.

Role change

Roger N. Farah

Chair of the Board

CVS · CVS HEALTH Corp

Effective: 2022-05-11
Filed: March 10, 2022, 6:59 PM ET

The Board of CVS Health has selected Roger N. Farah, an independent director of the Board and member of the Management Planning and Development and Medical Affairs Committees of the Board, to become Chair of the Board effective May 11, 2022, subject to his re-election at the Annual Meeting of Stockholders.

Departed

Tony L. White

Director

CVS · CVS HEALTH Corp

Effective: 2022-05-11
Filed: March 10, 2022, 6:59 PM ET

Mr. Tony L. White, an independent director of the Board of CVS Health, having reached mandatory retirement age, will also retire from the Board effective upon the Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David W. Dorman departed as Chair of the Board at CVS HEALTH Corp.

Action: retire
Role: Chair of the Board

Exact text from the filing

David W. Dorman, the current Chair of the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health”), informed the Board that he intends to retire at the end of his current term and will not stand for re-election at the Annual Meeting of Stockholders on May 11, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Roger N. Farah changed role as Chair of the Board at CVS HEALTH Corp.

Action: selected
Role: Chair of the Board

Exact text from the filing

The Board of CVS Health has selected Roger N. Farah, an independent director of the Board and member of the Management Planning and Development and Medical Affairs Committees of the Board, to become Chair of the Board effective May 11, 2022, subject to his re-election at the Annual Meeting of Stockholders.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Tony L. White departed as director at CVS HEALTH Corp.

Action: retire

Exact text from the filing

Mr. Tony L. White, an independent director of the Board of CVS Health, having reached mandatory retirement age, will also retire from the Board effective upon the Annual Meeting of Stockholders.

View on SEC.gov

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0000947871-22-000347

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.